X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (2) 2
analysis (2) 2
antigens (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
cancer therapies (2) 2
chemotherapy (2) 2
clinical trials (2) 2
humans (2) 2
index medicus (2) 2
male (2) 2
medical colleges (2) 2
metastasis (2) 2
middle aged (2) 2
patients (2) 2
product development (2) 2
2nd-line chemotherapy (1) 1
5-fluorouracil (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
abridged index medicus (1) 1
acids (1) 1
adenocarcinoma (1) 1
adult (1) 1
antibodies (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antigen (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents/therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
autoimmune diseases (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - adverse effects (1) 1
camptothecin - analogs & derivatives (1) 1
cancer (1) 1
carcinoma (1) 1
carcinoma, pancreatic ductal - drug therapy (1) 1
carcinoma, pancreatic ductal - mortality (1) 1
care and treatment (1) 1
castration-resistant/mortality/therapy (1) 1
cells (1) 1
combined modality therapy (1) 1
ctla-4 blockade (1) 1
cytotoxicity (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - adverse effects (1) 1
deoxycytidine - analogs & derivatives (1) 1
diarrhea (1) 1
diarrhea - chemically induced (1) 1
disease (1) 1
disease progression (1) 1
docetaxel (1) 1
double-blind method (1) 1
drug dosages (1) 1
drug stores (1) 1
drugstores (1) 1
equivalence (1) 1
fatigue - chemically induced (1) 1
fda approval (1) 1
female (1) 1
fluorouracil - administration & dosage (1) 1
fluorouracil - adverse effects (1) 1
folfiri (1) 1
folinic acid (1) 1
gemcitabine (1) 1
hematology, oncology and palliative medicine (1) 1
hepatitis (1) 1
immunotherapy (1) 1
interactive systems (1) 1
internal medicine (1) 1
ipilimumab (1) 1
irinotecan (1) 1
kaplan-meier estimate (1) 1
leucovorin (1) 1
leucovorin - administration & dosage (1) 1
leucovorin - adverse effects (1) 1
life sciences (1) 1
liposomes (1) 1
lymphatic system (1) 1
medical prognosis (1) 1
medical treatment (1) 1
medicine, general & internal (1) 1
melanoma (1) 1
metastases (1) 1
monoclonal antibodies (1) 1
monoclonal/therapeutic use (1) 1
motivation (1) 1
nanoparticles (1) 1
neoplasm metastasis (1) 1
neutropenia (1) 1
neutropenia - chemically induced (1) 1
oncology (1) 1
open-label (1) 1
oxaliplatin (1) 1
pancreatic cancer (1) 1
pancreatic neoplasms - drug therapy (1) 1
pancreatic neoplasms - mortality (1) 1
pep02 (1) 1
plus gemcitabine (1) 1
prostate cancer (1) 1
prostatic neoplasms (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 700 - 712
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10018, pp. 545 - 557
Summary Background Nanoliposomal irinotecan showed activity in a phase 2 study in patients with metastatic pancreatic ductal adenocarcinoma previously treated... 
Internal Medicine | PLUS GEMCITABINE | SURVIVAL | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | ADENOCARCINOMA | 2ND-LINE CHEMOTHERAPY | OXALIPLATIN | PEP02 | DOCETAXEL | CARCINOMA | FOLFIRI | Leucovorin - administration & dosage | Humans | Middle Aged | Male | Fatigue - chemically induced | Diarrhea - chemically induced | Pancreatic Neoplasms - drug therapy | Neoplasm Metastasis | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Camptothecin - administration & dosage | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Pancreatic Ductal - drug therapy | Irinotecan | Vomiting - chemically induced | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Liposomes | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Pancreatic cancer | Leucovorin | Product development | Research institutes | Metastasis | Antineoplastic agents | Analysis | Antigens | Chemotherapy | Medical prognosis | Clinical trials | Drug dosages | Cancer therapies | Tumors | Adenocarcinoma | Slopes | Therapy | Gemcitabine | Toxicity | Metastases | Nanoparticles | Randomization | Motivation | Vomiting | Safety management | Toxic diseases | Neutropenia | Folinic acid | Lymphatic system | Medical treatment | Diarrhea | FDA approval | Survival | Patients | Acids | Equivalence | Interactive systems
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.